These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 8536517)
1. Alpha-fetoprotein and p53 autoantibodies in patients with chronic hepatitis C. Raedle J; Roth WK; Oremek G; Caspary WF; Zeuzem S Dig Dis Sci; 1995 Dec; 40(12):2587-94. PubMed ID: 8536517 [TBL] [Abstract][Full Text] [Related]
2. Anti-p53 autoantibodies in hepatitis C virus-infected patients. Raedle J; Oremek G; Roth WK; Caspary WF; Zeuzem S Anticancer Res; 1997; 17(4B):3079-81. PubMed ID: 9329606 [TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of autoantibodies to p53 protein in patients with chronic liver disease and hepatocellular carcinoma. Raedle J; Oremek G; Truschnowitsch M; Lorenz M; Roth WK; Caspary WF; Zeuzem S Eur J Cancer; 1998 Jul; 34(8):1198-203. PubMed ID: 9849479 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma. Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803 [TBL] [Abstract][Full Text] [Related]
5. The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alpha-fetoprotein status. Volkmann M; Müller M; Hofmann WJ; Meyer M; Hagelstein J; Räth U; Kommerell B; Zentgraf H; Galle PR Hepatology; 1993 Sep; 18(3):559-65. PubMed ID: 7689531 [TBL] [Abstract][Full Text] [Related]
6. A comparison between alpha-fetoprotein and p53 antibodies in the diagnosis of hepatocellular carcinoma. Edis C; Kähler C; Klotz W; Herold M; Feichtinger H; Königsreiner A; Margreiter R; Jaschke W; Vogel W Transplant Proc; 1998 May; 30(3):780-1. PubMed ID: 9595095 [No Abstract] [Full Text] [Related]
7. The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis. Arrieta O; Cacho B; Morales-Espinosa D; Ruelas-Villavicencio A; Flores-Estrada D; Hernández-Pedro N BMC Cancer; 2007 Feb; 7():28. PubMed ID: 17288606 [TBL] [Abstract][Full Text] [Related]
8. Specificities of serum alpha-fetoprotein in HBsAg+ and HBsAg- patients in the diagnosis of hepatocellular carcinoma. Lee HS; Chung YH; Kim CY Hepatology; 1991 Jul; 14(1):68-72. PubMed ID: 1712341 [TBL] [Abstract][Full Text] [Related]
9. Combined detection of AFP-L3, GP73 and TIP30 enhances diagnostic accuracy for HBV-related cirrhosis and hepatocellular carcinoma. Yanming L; Yue C; Wencan C; Liangyin WU; Xijun L; Jiafeng Z; Fengping HE J Pak Med Assoc; 2019 Sep; 69(9):1279-1286. PubMed ID: 31511712 [TBL] [Abstract][Full Text] [Related]
10. The Updated Model: An Adjusted Serum Alpha-Fetoprotein-Based Algorithm for Hepatocellular Carcinoma Detection With Hepatitis C Virus-Related Cirrhosis. White DL; Richardson P; Tayoub N; Davila JA; Kanwal F; El-Serag HB Gastroenterology; 2015 Dec; 149(7):1986-7. PubMed ID: 26519622 [No Abstract] [Full Text] [Related]
11. Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model. Zekri AR; Youssef AS; Bakr YM; Gabr RM; Ahmed OS; Elberry MH; Mayla AM; Abouelhoda M; Bahnassy AA World J Gastroenterol; 2016 Apr; 22(16):4168-82. PubMed ID: 27122667 [TBL] [Abstract][Full Text] [Related]
12. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development]. Kim KA; Lee JS; Jung ES; Kim JY; Bae WK; Kim NH; Moon YS Korean J Gastroenterol; 2006 Nov; 48(5):321-6. PubMed ID: 17132920 [TBL] [Abstract][Full Text] [Related]
13. Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Nishiguchi S; Kuroki T; Nakatani S; Morimoto H; Takeda T; Nakajima S; Shiomi S; Seki S; Kobayashi K; Otani S Lancet; 1995 Oct; 346(8982):1051-5. PubMed ID: 7564784 [TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of transiently elevated serum AFP level in developing hepatocellular carcinoma in HBsAg positive-liver cirrhosis]. Lee HY; Jung JH; Kang YS; Kim YS; Moon HS; Park KO; Lee YS; Kim SM; Seo SW; Lee SW; Kim SH; Lee BS; Kim NJ Korean J Gastroenterol; 2004 Apr; 43(4):252-9. PubMed ID: 15100489 [TBL] [Abstract][Full Text] [Related]
16. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961 [TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area. Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364 [TBL] [Abstract][Full Text] [Related]
18. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus. Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524 [TBL] [Abstract][Full Text] [Related]
19. Assessment of the Clinical Utility of Glypican 3 as a Serum Marker for the Diagnosis of Hepatocellular Carcinoma. Jia X; Gao Y; Zhai D; Liu J; Cai J; Wang Y; Jing L; Du Z Technol Cancer Res Treat; 2016 Dec; 15(6):780-786. PubMed ID: 26370140 [TBL] [Abstract][Full Text] [Related]